PROTAC ER Degrader-2 serves as a synthesis intermediate for the production of PAC, a compound that incorporates the ADCs linker and PROTACs, which are subsequently conjugated to an antibody. PAC, exhibits a greater capability to degrade estrogen receptor-alpha (ERalpha) compared to PROTAC (without the presence of an antibody)[1].
Molecular Weight:
1581.85
Formula:
C89H104N12O15
Target:
Estrogen Receptor/ERR|||PROTACs|||Others
T18606
* VAT and and shipping costs not included. Errors and price changes excepted
